ACNE THERAPEUTICS MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2025-2032)

Acne Therapeutics Market, By Treatment (Therapeutics, Retinoid, Antibiotics, Hormonal Agents, Combination Medications, Anti-inflammatory, and Other Agents) and By Route of Administration (Oral, Topical, and Others), And By Geography (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa)

Published In: 19 Nov, 2025
Code: CMI5182
Pages: 155
Formats: Excel and PDF
Industry: Pharmaceutical
- Historical Range: 2020 - 2024
- Forecast Period: 2025 - 2032

Acne is the common skin condition where the pores of the skin clog, and pore blockages leads to blackheads, whiteheads, and/or pimples. Acne affect around 9.4% of the global population, making it one of the most prevalent disease worldwide. Hence, there is an increasing demand for safe and effective acne therapeutics. Acne therapeutics include over-the-counter creams, gels, and cleanser, as well as prescription antibiotics.

Market Dynamics

Increasing prevalence of acne, increasing demand for safe/effective acne therapeutics, increasing research and development (R&D), and growing awareness among people about acne products and available treatment options are some major factors expected to augment the growth of the global acne therapeutics market during the forecast period.

For instance, in July 2022, STRATA Skin Sciences, Inc. announced the launch of TheraClearX, a non-invasive, in-office acne treatment targeting the root causes of mild to moderate acne, including comedonal, pustular, and inflammatory acne vulgaris.

Key features of the study

This report provides in-depth analysis of the global acne therapeutics market, and provides market size (US$ Million) and compound annual growth rate (CAGR%) for the forecast period 2025-2032, considering 2024 as the base year.
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
It profiles key players in the global acne therapeutics market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies.
Key companies covered as a part of this study include Allergan, Ranbaxy, Bayer Ag, Johnson & Johnson, Nestlé SA (Galderma), Glaxosmithkline Plc, Teva Pharmaceuticals, Cipher Pharmaceuticals, F. Hoffmann-la Roche Ltd., and Valeant Pharmaceuticals International Inc., among others.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
The global acne therapeutics market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global acne therapeutics market.

Market Segmentation

Global Acne Therapeutics Market, By Treatment
- Therapeutics
- Retinoid
- Antibiotics
- Hormonal Agents, Combination Medications, Anti-inflammatory
- Other Agents
Global Acne Therapeutics Market, By Route of Administration
- Oral
- Topical
- Others
Global Acne Therapeutics Market, By Geography
- North America
  - U.S.
  - Canada
- Latin America
  - Brazil
  - Argentina
  - Mexico
  - Rest of Latin America
- Europe
  - Germany
  - U.K.
  - Spain
  - France
  - Italy
  - Russia
  - Rest of Europe
- Asia Pacific
  - China
  - India
  - Japan
  - Australia
  - South Korea
  - ASEAN
  - Rest of Asia Pacific
- Middle East
  - GCC Countries
  - Israel
  - Rest of Middle East
- Africa
  - South Africa
  - North Africa
  - Central Africa
Company Profiles
- Allergan
- Ranbaxy
- Bayer Ag
- Johnson & Johnson
- Nestlé SA (Galderma)
- Glaxosmithkline Plc
- Teva Pharmaceuticals
- Cipher Pharmaceuticals
- F.Hoffmann-la Roche Ltd.
- Valeant Pharmaceuticals International Inc.

Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
Market Purview
- Report Description
  - Market Definition and Scope
- Executive Summary
  - Market Snapshot, By Treatment
  - Market Snapshot, By Route of Administration
  - Market Snapshot, By Geography
- Coherent Opportunity Map (COM)
Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
  - Increasing prevalence of acne
  - Increasing demand for generics
  - High demand for acne therapeutics
- Impact Analysis
- Key Highlights
- Regulatory Scenario
- Product launch/Approvals
- PEST Analysis
- PORTER’s Analysis
- Merger and Acquisition Scenario
Global Acne Therapeutics Market, By Treatment, 2020-2032, (US$ Mn)
- Introduction
  - Market Share Analysis, 2025 and 2032 (%)
  - Y-o-Y Growth Analysis, 2021 – 2032
  - Segment Trends
- Therapeutics
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
- Retinoid
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
- Antibiotics
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
- Hormonal Agents
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
- Combination Medications
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
- Anti-inflammatory
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
- Other Agents
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
Global Acne Therapeutics Market, By Route of Administration, 2020-2032, (US$ Mn)
- Introduction
  - Market Share Analysis, 2025 and 2032 (%)
  - Y-o-Y Growth Analysis, 2021 – 2032
  - Segment Trends
- Oral
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
- Topical
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
- Others
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
Global Acne Therapeutics Market, By Geography, 2020-2032, (US$ Mn)
- Introduction
  - Market Share Analysis, 2025 and 2032 (%)
  - Y-o-Y Growth Analysis, 2021 – 2032
  - Segment Trends
- North America
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Treatment, 2020-2032,(US$ Mn)
  - Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020-2032,(US$ Mn)
  - Market Size and Forecast, By Country, 2020–2032, (US$ Mn)
    - U.S.
    - Canada
- Latin America
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Treatment, 2020-2032, (US$ Mn)
  - Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020-2032,(US$ Mn)
  - Market Size and Forecast, By Country, 2020–2032, (US$ Mn)
    - Brazil
    - Argentina
    - Mexico
    - Rest of Latin America
- Europe
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Treatment, 2020-2032, (US$ Mn)
  - Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020-2032,(US$ Mn)
  - Market Size and Forecast, By Country, 2020–2032, (US$ Mn)
    - Germany
    - U.K.
    - Spain
    - France
    - Italy
    - Russia
    - Rest of Europe
- Asia Pacific
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Treatment, 2020-2032, (US$ Mn)
  - Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020-2032, (US$ Mn)
  - Market Size and Forecast, By Country, 2020–2032, (US$ Mn)
    - China
    - India
    - Japan
    - ASEAN
    - Australia
    - South Korea
    - Rest of Asia Pacific
- Middle East & Africa
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Treatment, 2020-2032, (US$ Mn)
  - Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020-2032, (US$ Mn)
    - South Africa
    - Israel
    - GCC Countries
    - Rest of the Middle East &Africa
Competitive Landscape

Allergan

Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies

Ranbaxy

Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies

Bayer AG

Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies

Johnson & Johnson

Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies

Nestlé SA (Galderma)

Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies

Glaxosmithkline Plc

Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies

Teva Pharmaceuticals

Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies

Cipher Pharmaceuticals

Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies

F. Hoffmann-la Roche Ltd.

Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies

Valeant Pharmaceuticals International Inc.

Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies

Analyst Views

Section

Research Methodology
About us

Limited Time Offer - Buy Now

Need a Custom Report?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports
Customize Now